397 related articles for article (PubMed ID: 30783370)
1. Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies.
Fung BM; Lindor KD; Tabibian JH
World J Gastroenterol; 2019 Feb; 25(6):659-671. PubMed ID: 30783370
[TBL] [Abstract][Full Text] [Related]
2. Cancer risk, screening and surveillance in primary sclerosing cholangitis.
Chascsa DM; Lindor KD
Minerva Gastroenterol Dietol; 2019 Sep; 65(3):214-228. PubMed ID: 31220911
[TBL] [Abstract][Full Text] [Related]
3. Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study.
Yu J; Refsum E; Helsingen LM; Folseraas T; Ploner A; Wieszczy P; Barua I; Jodal HC; Melum E; Løberg M; Blom J; Bretthauer M; Adami HO; Kalager M; Ye W
United European Gastroenterol J; 2022 Mar; 10(2):212-224. PubMed ID: 35107865
[TBL] [Abstract][Full Text] [Related]
4. Cancer surveillance in patients with primary sclerosing cholangitis.
Razumilava N; Gores GJ; Lindor KD
Hepatology; 2011 Nov; 54(5):1842-52. PubMed ID: 21793028
[TBL] [Abstract][Full Text] [Related]
5. [Primary sclerosing cholangitis].
Boonstra K; Ponsioen CI; Rauws EA; Beuers U
Ned Tijdschr Geneeskd; 2010; 154():A1476. PubMed ID: 20619015
[TBL] [Abstract][Full Text] [Related]
6. Screening for malignancy in primary sclerosing cholangitis (PSC).
Khaderi SA; Sussman NL
Curr Gastroenterol Rep; 2015 Apr; 17(4):17. PubMed ID: 25786901
[TBL] [Abstract][Full Text] [Related]
7. Primary sclerosing cholangitis-associated cholangiocarcinoma: special considerations and best practices.
Fung BM; Tabibian JH
Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):487-496. PubMed ID: 33682586
[No Abstract] [Full Text] [Related]
8. Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat.
Bonato G; Cristoferi L; Strazzabosco M; Fabris L
Dig Dis; 2015; 33 Suppl 2(Suppl 2):140-8. PubMed ID: 26641079
[TBL] [Abstract][Full Text] [Related]
9. Recent insights in primary sclerosing cholangitis.
Ponsioen CY
J Dig Dis; 2012 Jul; 13(7):337-41. PubMed ID: 22713082
[TBL] [Abstract][Full Text] [Related]
10. Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics.
Ehlken H; Schramm C
Dig Dis; 2013; 31(1):118-25. PubMed ID: 23797133
[TBL] [Abstract][Full Text] [Related]
11. AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review.
Bowlus CL; Lim JK; Lindor KD
Clin Gastroenterol Hepatol; 2019 Nov; 17(12):2416-2422. PubMed ID: 31306801
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease.
Manninen P; Karvonen AL; Laukkarinen J; Aitola P; Huhtala H; Collin P
Scand J Gastroenterol; 2015 Apr; 50(4):423-8. PubMed ID: 25636976
[TBL] [Abstract][Full Text] [Related]
13. Cancer Risk and Surveillance in Primary Sclerosing Cholangitis.
Folseraas T; Boberg KM
Clin Liver Dis; 2016 Feb; 20(1):79-98. PubMed ID: 26593292
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
Bergquist A; Glaumann H; Persson B; Broomé U
Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625
[TBL] [Abstract][Full Text] [Related]
15. Primary sclerosing cholangitis.
Milkiewicz P; Wunsch E
Recent Results Cancer Res; 2011; 185():117-33. PubMed ID: 21822823
[TBL] [Abstract][Full Text] [Related]
16. Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma.
Boyd S; Mustonen H; Tenca A; Jokelainen K; Arola J; Färkkilä MA
Scand J Gastroenterol; 2017 Feb; 52(2):242-249. PubMed ID: 27806633
[TBL] [Abstract][Full Text] [Related]
17. Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management.
Ilyas SI; Eaton JE; Gores GJ
Clin Gastroenterol Hepatol; 2015 Nov; 13(12):2152-65. PubMed ID: 26051390
[TBL] [Abstract][Full Text] [Related]
18. Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options.
Franceschet I; Cazzagon N; Del Ross T; D'Incà R; Buja A; Floreani A
Eur J Gastroenterol Hepatol; 2016 May; 28(5):508-13. PubMed ID: 26872110
[TBL] [Abstract][Full Text] [Related]
19. Primary Sclerosing Cholangitis: What the Gastroenterologist and Hepatologist Needs to Know.
Gossard AA; Gores GJ
Clin Liver Dis; 2017 Nov; 21(4):725-737. PubMed ID: 28987259
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features.
Palmela C; Peerani F; Castaneda D; Torres J; Itzkowitz SH
Gut Liver; 2018 Jan; 12(1):17-29. PubMed ID: 28376583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]